InkVivo leverages scalable manufacturing approaches with its biomaterial platform to fabricate innovative drug delivery systems. Our unique ability relies in controlling the spatial composition and formulation of the designed systems, which result in targeted and temporal controlled release of active ingredients (e.g., small molecules, biologics, and micronutrients) increasing their bioavailability.
InkVivo provides:
1) Enginering support for (new) drug development;
2) Reformulation and relaunching existing drug delivery systems; and
3) Life cycle management of existing drugs
Company Details
- Employees
- 7
- Founded
- -
- Address
- Sonneggstrasse 3, Ethz Ml H22,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://inkvivo.tech
- Keywords
- Biomaterials, Gastroretentive formulations, Drug formulations, Injectable formulations, Advanced manufacturing, nano/micro encapsulation, Drug reformulation, Patient centric therapies.
- HQ
- Zurich
Inkvivo Technologies Ag Questions
Inkvivo Technologies Ag's website is https://inkvivo.tech
Inkvivo Technologies Ag's LinkedIn profile is https://ch.linkedin.com/company/inkvivo
Inkvivo Technologies Ag has
7 employees.
View email and phone details for 7
employees at Inkvivo Technologies Ag.
Inkvivo Technologies Ag's industry is
Biotechnology Research
Inkvivo Technologies Ag's top competitors are
Tandem Therapeutics,
Adularia,
Muvon Therapeutics Ag,
Btry,
Customsurg,
Nanoflex Robotics,
Enantios,
Navignostics Ag,
Araris Biotech Ag,
Juvion Health Sciences.
Inkvivo Technologies Ag's categories are Biotechnology Research
Inkvivo Technologies Ag's founding year is 2023
